The traditional complications of diabetes mellitus are well known and continue to pose a
considerable burden on millions of people living with diabetes mellitus. However, advances …

Diabetes, a silent killer, is one of the most widely prevalent conditions of the present time.
According to the 2017 International Diabetes Federation (IDF) statistics, the global …

Since its inception in 2004, the “Clinical Practice Guidelines for the Treatment of Diabetes”
has attempted to promote evidence-based, rational, efficient and standardized clinical …

The prevalence of diabetes is dramatically increasing worldwide. The results of numerous
epidemiological studies indicate that diabetic population is not only at increased risk of …

Context With increasing globalization and East-West exchanges, the increasing epidemic of
type 2 diabetes in Asia has far-reaching public health and socioeconomic implications …

Background A growing body of evidence has suggested that metformin potentially reduces
the risk of cancer. Our objective was to enhance the precision of estimates of the effect of …

Diabetes and cancer are two heterogeneous, multifactorial, severe, and chronic diseases.
Because of their frequency, reciprocal influences–even minor influences–may have a major …

Aims/hypothesis The risk of developing a range of solid tumours is increased in type 2
diabetes, and may be influenced by glucose-lowering therapies. We examined the risk of …

As the prevalence of diabetes mellitus is substantially increasing worldwide, associated
diseases such as renal failure, cardiovascular diseases, fatty liver, and cancers have also …

ContextThe natural history of biochemical recurrence after radical prostatectomy can be long
but variable. Better risk assessment models are needed to identify men who are at high risk …